Gvhd after PBSC-Haploidentical Stem Cell Transplantation (Haplo-SCT) with Post Transplantation-Cyclophosphamide (PT-Cy)

被引：0
|
作者：
Granata, Angela
Devillier, Raynier
Bramanti, Stefania
Furst, Sabine
Legrand, Faezeh
Harbi, Samia
Faucher, Catherine
Chabannon, Christian
Lemarie, Claude
Calmels, Boris
Mariotti, Jacopo
Maisano, Valerio
Weiller, Pierre Jean
Castagna, Luca
Blaise, Didier
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1984
引用
收藏
页数：2
相关论文
共 50 条
  • [1] POST-TRANSPLANT CYCLOPHOSPHAMIDE (PT-CY) IS EFFECTIVE TO PREVENT GVHD AFTER T-CELL REPLETE HAPLOIDENTICAL PERIPHERAL BLOOD STEM CELL TRANSPLANTATION (HAPLO-SCT)
    Granata, A.
    Fuerst, S.
    Castagna, L.
    Devillier, R.
    El Cheikh, J.
    Harbi, S.
    Faucher, C.
    Charbonnier, A.
    Stoppa, A. M.
    Aurran, T.
    Calmels, B.
    Lemarie, C.
    Picard, C.
    Crocchiolo, R.
    Bouhabdallah, R.
    Chabannon, C.
    Vey, N.
    Blaise, D.
    [J]. HAEMATOLOGICA, 2015, 100 : 117 - 117
  • [2] Tacrolimus (FK) compared to cyclosporine A (CyA) after haploidentical T cell replete stem cell transplantation (Haplo-SCT) with post-infusion cyclophosphamide (PT-Cy): a retrospective analysis
    Castagna, L.
    Bramanti, S.
    Furst, S.
    Sarina, B.
    Crocchiolo, R.
    Giordano, L.
    El-Cheikn, J.
    Granata, A.
    Morabito, L.
    Faucher, C.
    Mothy, B.
    Harbi, S.
    Chabannon, C.
    Stella, C. Carlo
    Santoro, A.
    Blaise, D.
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 : S184 - S185
  • [3] Feasibility of Modified CD45RA Negative Donor Lymphocytes Infusion after Haploidentical Stem Cell Transplantation (HAPLO-SCT) with Post-transplantation Cyclophosphamide (PT-Cy) in Patients with Hematological Malignancies
    Bramanti, Stefania
    Magri, Filippo
    De Paoli, Federica
    Van Beek, Jasper
    Barbara, Sarina
    Timofeeva, Inna Anatolievna
    Mariotti, Jacopo
    Capizzuto, Rossana
    Chiara, De Philippis
    Mavilio, Domenico
    Santoro, Armando
    Lugli, Enrico
    Castagna, Luca
    [J]. BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 684 - 685
  • [4] Low Incidence of Chronic Gvhd after Haploidentical T-Cell Replete Peripheral Blood Stem Cell Transplantation with Post Transplantation Cyclophosphamide (PT-Cy)
    Granata, Angela
    Furst, Sabine
    Boher, Jean Marie
    Castagna, Luca
    Chevallier, Patrice
    Garnier, Alice
    Guillaume, Thierry
    Dulery, Remy
    Mohty, Mohamad
    Legrand, Faezeh
    Harbi, Samia
    Devillier, Raynier
    Faucher, Catherine
    Bramanti, Stefania
    Lemarie, Claude
    Calmels, Boris
    Weiller, Pierre Jean
    Chabannon, Christian
    Blaise, Didier
    [J]. BLOOD, 2016, 128 (22)
  • [5] HAPLOIDENTICAL STEM CELL TRANSPLANTATION (HAPLO-SCT) WITH REDUCED INTENSITY CONDITIONING (RIC) REGIMENS AND HIGH DOSE CYLOPHOSPHAMIDE POST-TRANSPLANT (PT-CY) AS GVHD PROPHYLAXIS IN PATIENTS WITH RELAPSED OR REFRACTORY HODGKIN'S DISEASE
    Gayoso, J.
    Balsalobre, P.
    Castilla, C.
    Jesus Pascual, M.
    Kwon, M.
    Serrano, D.
    Lopez-Corral, L.
    Antonio Perez-Simon, J.
    Bermudez, A.
    Martinez, C.
    Pascual, C.
    Heras, I.
    Solano, C.
    Figuera, A.
    Antonia Sampol, M.
    Ferra, C.
    Herrera, P.
    Buno, I.
    Luis Diez-Martin, J.
    [J]. BONE MARROW TRANSPLANTATION, 2014, 49 : S166 - S167
  • [6] Myeloablative Haploidentical Stem Cell Transplantation (MAC-HAPLO) with Post-Transplant Cyclophosphamide (PT-CY) As GVHD Prophylaxis in High Risk Leukemias/Myelosdisplastic Syndromes (MDS)
    Gayoso, Jorge
    Balsalobre, Pascual
    Kwon, Mi
    Sampol, Antonia
    Montesinos, Pau
    Serrano, David
    Herrera, Pilar
    Jesus Pascual, Maria
    Bermudez, Arancha
    Castilla-Llorente, Cristina
    Bento, Leyre
    Champ, Diana
    Perez-Corral, Ana
    Buces, Elena
    Luis Diez-Martin, Jose
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S186 - S186
  • [7] HAPLOIDENTICAL STEM CELL TRANSPLANTATION (HAPLO-HSCT) WITH HIGH DOSE CYLOPHOSPHAMIDE POST-TRANSPLANT (PT-CY) AS GVHD PROPHYLAXIS IN HIGH RISK HEMATOLOGIC
    Gayoso, J.
    Balsalobre, P.
    Kwon, M.
    Jesus Pascual, M.
    Castilla, C.
    Serrano, D.
    Lopez-Corral, L.
    Antonio Perez-Simon, J.
    Bermudez, A.
    Rovira, M.
    Perez-Corral, A.
    Anguita, J.
    Heras, I.
    Solano, C.
    Figuera, A.
    Antonia Sampol, M.
    Ferra, C.
    Herrera, P.
    Sonia Gonzalez, M.
    Montesinos, P.
    Buno, I.
    Luis Diez-Martin, J.
    [J]. BONE MARROW TRANSPLANTATION, 2014, 49 : S280 - S280
  • [8] Long-Term Outcomes After Haploidentical Stem Cell Transplantation (Haplo-SCT) for Hematologic Malignancies
    Saengboon, Supawee
    Ramdial, Jeremy
    Saini, Neeraj
    Olson, Amanda
    Im, Jin
    Hosing, Chitra
    Popat, Uday
    Shpall, Elizabeth
    Champlin, Richard
    Srour, Samer
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S259 - S260
  • [9] Tacrolimus (FK) Compared to Cyclosporine a (CyA) after Haploidentical T Cell Replete Stem Cell Transplantation (Haplo-SCT) with Post-Infusion Cyclophosphamide: A Retrospective Analysis
    Castagna, Luca
    Bramanti, Stefania
    Furst, Sabine
    Sarina, Barbara
    Crocchiolo, Roberto
    Giordano, Laura
    El Cheikh, Jean
    Granata, Angela
    Morabito, Lucio
    Mauro, Elisa
    Faucher, Catherine
    Mothy, Bilal
    Harbi, Samia
    Chabannon, Christian
    Carlo-Stella, Carmelo
    Santoro, Armando
    Blaise, Didier
    [J]. BLOOD, 2014, 124 (21)
  • [10] Haploidentical Hematopoietic Stem Cell Transplantation (Haplo-SCT) with Pre-Transplant Immunosuppression (PTIS) Followed by Reduced Toxicity Regimen and Post-Transplant Cyclophosphamide (Post-Cy) in Severe Thalassemia
    Hongeng, S.
    Anurathapan, U.
    Pakakasama, S.
    Andersson, B.
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 : S88 - S88
12345